BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 696185)

  • 1. Demonstration of human chorionic gonadotropin during the second half of the menstrual cycle in plasma of regularly menstruating women users of copper IUds.
    Capitanio GL; Conte N; Ragni N; Rossato P; Pedretti E
    Acta Eur Fertil; 1978 Mar; 9(1):11-9. PubMed ID: 696185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy-specific beta 1-glycoprotein and chorionic gonadotropin-like immunoreactivity during the latter half of the cycle in women using intrauterine contraception.
    Seppälä M; Rutanen EM; Jalanko H; Lehtovirta P; Stenman UH; Engvall E
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1216-9. PubMed ID: 318094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human chorionic gonadotropin in intrauterine device users.
    Shalit A; Jaschevatzky OE; Kampf D; Leiserowitz DM; Grünstein S
    Int J Fertil; 1980; 25(2):134-6. PubMed ID: 6117529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of chorionic gonadotropin in sera of women who use intrauterine devices.
    Segal SJ; Alvarez-Sanchez F; Adejuwon CA; Brache de Mejia V; Leon P; Faundes A
    Fertil Steril; 1985 Aug; 44(2):214-8. PubMed ID: 4018277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chorionic gonadotropin in women fitted with intrauterine device.
    Yarkoni S; Zer TA; Schenker JG
    Infertility; 1980; 3(1):23-7. PubMed ID: 12263338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of beta subunit HCG in plasma of IUD users as an indication of frequency of conception.
    Nilsson CG; Lähteenmäki P; Luukkainen T
    Int J Fertil; 1979; 24(2):134-7. PubMed ID: 40908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary human chorionic gonadotropin among intrauterine device users: detection with a highly specific and sensitive assay.
    Wilcox AJ; Weinberg CR; Armstrong EG; Canfield RE
    Fertil Steril; 1987 Feb; 47(2):265-9. PubMed ID: 3817172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal profile in IUD users.
    Souka AR; Rahman H; Osman M; Mohei Y; Rizk M
    Contracept Deliv Syst; 1981 Oct; 2(4):303-10. PubMed ID: 12336991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of human chorionic gonadotropin in blood of regularly bleeding women using copper intrauterine contraceptive devices.
    Landesman R; Coutinho EM; Saxena BB
    Fertil Steril; 1976 Sep; 27(9):1062-6. PubMed ID: 964399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of the copper-T 200 IUD on the luteal phase plasma progesterone concentration in the normal menstrual cycle.
    Haukkamaa M; Luukkainen T; Timonen H
    Ann Clin Res; 1974 Feb; 6(1):40-4. PubMed ID: 4820609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the human blastocyst implant in the presence of an IUD?
    Res Reprod; 1977 Nov; 9(6):4. PubMed ID: 12260213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaginal pH effects caused by OCs and various copper and inert IUDs.
    Kandil O; Hassanein MK; El-tagi A; El-shirbini MT
    Contracept Deliv Syst; 1983 Jul; 4(3):187-93. PubMed ID: 12265361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal characteristics in the early luteal phase of conceptive and nonconceptive menstrual cycles.
    Chen J; Qiu Q; Lohstroh PN; Overstreet JW; Lasley BL
    J Soc Gynecol Investig; 2003 Jan; 10(1):27-31. PubMed ID: 12517590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma insulin and glucagon concentrations and biochemical variables in regularly menstruating females with ovulatory and anovulatory menstrual cycles.
    Lutosławska G; Skierska E; Keska A; Byszewska-Szpocińska E
    Horm Metab Res; 2003 Jul; 35(7):444-50. PubMed ID: 12931277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of elevated circulating levels of LH during the pre-menstrual period in some copper IUD users and the possibility of their confusion with hCG.
    Dattatreyamurty B; Joshi J; Mehta S; Virkar KD; Sheth AR
    Contraception; 1979 Mar; 19(3):213-21. PubMed ID: 455978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human chorionic gonadotrophin (hCG) in IUD users.
    Dhont M; Thiery M; Vanlancker M
    IRCS J Med Sci; 1984 Sep; 12(9):862. PubMed ID: 12340100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wider opportunities for IUD insertion.
    Cole LP; Potts DM
    IPPF Med Bull; 1983 Feb; 17(1):2-3. PubMed ID: 12264751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of circulating chorionic gonadotropin in wearers of intrauterine contraceptive devices.
    Klein TA; Mishell DR
    Am J Obstet Gynecol; 1977 Nov; 129(6):626-8. PubMed ID: 920763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The intra-uterine contraceptive device--contraceptive or abortifacient?
    Kort H; van der Walt LA
    S Afr Med J; 1978 May; 53(21):864-6. PubMed ID: 358422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malonaldehyde production around copper IUDs.
    Briggs MH
    Contracept Deliv Syst; 1982 Apr; 3(2):141-8. PubMed ID: 12338168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.